Status:
RECRUITING
RFA Treatment for Papillary Thyroid Microcarcinoma
Lead Sponsor:
Columbia University
Conditions:
Papillary Thyroid Microcarcinoma
Eligibility:
All Genders
18+ years
Brief Summary
Thyroid surgery has always been the mainstay of treatment for thyroid cancer. Thyroid surgery carries a low risk of complications that include recurrent or superior laryngeal nerve injury leading to v...
Detailed Description
Differentiated thyroid cancer (DTC), which includes papillary and follicular cancer, comprises the vast majority (\>90%) of all thyroid cancers. The yearly incidence has nearly tripled from 4.9 per 10...
Eligibility Criteria
Inclusion
- Adult patients (\>/= 18 years)
- Biopsy proven papillary thyroid microcarcinoma (\>/= 1.5cm in greatest diameter, PTMC)
- Either refuse surgery or are not good surgical candidates
Exclusion
- Cardiac arrhythmia
- Pregnancy
Key Trial Info
Start Date :
November 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2027
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05189821
Start Date
November 1 2021
End Date
November 1 2027
Last Update
May 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University
New York, New York, United States, 10032